Abnormalities of Lymphocyte Subsets in Canine Systemic Lupus Erythematosus

References

• Jones D. R.E. Canine systemic lupus erythematosus: new insights and their implications. J. Comp. Path. 1993; 108: 215–228
   PubMed Web of Science ®Google Scholar
• Lewis R. M., Schwartz R. S., Henri W. B. Canine systemic lupus erythematosus. Blood 1965; 25: 143–160
   PubMed Web of Science ®Google Scholar
• Lewis R. M. Animal model of human disease: canine systemic lupus erythematosus. Am. J. Pathol. 1975; 69: 537–540
   Google Scholar
• Monier J. C. Le lupus du chien pour mieux comprendre le lupus humain. Path. Biol. 1981; 29: 261–264
   PubMedGoogle Scholar
• Monier J. C., Dardenne M., Rigal D., Costa O., Fournel C., Lapras M. Clinical and laboratory features of canine lupus syndromes. Arthritis Rheum. 1980; 23: 294–301
   PubMedGoogle Scholar
• Fournel C., Chabanne L., Caux C., Faure J. R., Rigal D., Magnol J. P., Monier J. C. Canine systemic lupus erythematosus. I: A study of 75 cases. Lupus 1992; 1: 133–139
   PubMed Web of Science ®Google Scholar
• Monier J. C., Ritter J., Caux C., Chabanne L., Fournel C., Venet C., Rigal D. Canine systemic lupus erythematosus. II: Antinuclear antibodies. Lupus 1992; 1: 287–293
   PubMed Web of Science ®Google Scholar
• Powell R. J. Canine lessons for human lupus. Lupus 1995; 1: 285–286
   Google Scholar
• Powell R. J., Jones D. R. Can man's best friend provide clues to the aetiology of systemic lupus erythematosus?. Ann. Rheum. Dis. 1992; 51: 833–834
   PubMed Web of Science ®Google Scholar
• Cohen P. L. T-and B-cell abnormalities in systemic lupus. J. Invest. Dermatol. 1993; 100: 69S–72S
   PubMed Web of Science ®Google Scholar
• Handwerger B. S. Lymphocyte biology in lupus. Curr. Opin. Rheumatol. 1991; 2: 749–761
   Google Scholar
• Tsokos G. C. Lymphocyte abnormalities in human lupus. Clin. Immunol. Immunopathol. 1992; 63: 7–9
   PubMedGoogle Scholar
• Rigal D., Bendali-Ahcene S., Monier J. C., Mohanna K., Fournel C. Identification of canine T lymphocytes by membrane receptor to peanut agglutinin: T-lymphocyte identification in dogs with lupus-like syndrome. Am. J. Vet. Res. 1983; 44: 1782–1785
   PubMed Web of Science ®Google Scholar
• Monier J. C., Fournel C., Lapras M., Dardenne M., Randle T., Fontaine M. Systemic lupus erythematosus in a colony of dogs. Am. J. Vet. Res. 1988; 49: 46–51
   PubMed Web of Science ®Google Scholar
• Cobbold S. P., Metcalfe S. Monoclonal antibodies that define canine homologues of human CD antigens: summary of the first International Canine Leucocyte Antigen Workshop (CLAW). Tissue Antigens 1994; 43: 137–154
   PubMedGoogle Scholar
• Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaffer J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Bombardier C., Gladman D. D., Urowitz M. B., Caron D., Chang C. H. and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI, a disease activity index for lupus patients. Arthritis Rheum. 1992; 35: 630–640
   PubMed Web of Science ®Google Scholar
• Chabanne L., Marchal T., Kaplanski C., Fournel C., Magnol J. P., Monier J. C., Rigal D. Screening of 78 monoclonal antibodies directed against human leukocyte antigens for cross-reactivity with surface markers on canine lymphocytes. Tissue Antigens 1994; 43: 202–205
   PubMedGoogle Scholar
• Jacobsen C. N., Aasted B., Broe M. K., Petersen J. L. Reactivities of 20 anti-human monoclonal antibodies with leucocytes from ten different animal species. Vet. Immunol. Immunopathol. 1993; 39: 461–466
   PubMed Web of Science ®Google Scholar
• Mysliwietz J., Hoffmann-Fezer G., Thierfelder S., Kolb H. J., Maldacker J. Recognition of two epitopes of an antigen present on canine T-cells but not on hemopoietic progenitors by four monoclonal antibodies. Transplantation 1988; 45: 443–448
   PubMed Web of Science ®Google Scholar
• Caux C., Rigal D., Kaplanski C., Fournel C., Chabanne L., Monier J. C. 2B3/1D4 a marker of activated canine T lymphocytes. Tissue Antigens 1994; 43, in press
   Google Scholar
• Winfield J. B., Mimura T. Pathogenic significance of anti-lymphocyte autoantibodies in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 1992; 63: 13–16
   PubMedGoogle Scholar
• Abdou N. I., Segawa A., Pascual E., Herdert J., Sadeghee S. T cell abnormality in idiopathic systemic lupus erythematosus. Clin. Immunol. Immunopathol. 1976; 6: 192–199
   PubMedGoogle Scholar
• Morimoto C., Reinherz E. L., Schlossman S. F., Schur P. H., Mills J. A., Steinberg A. D. Alteration of immunoregulatory T cell subsets in active SLE. J. Clin. Invest. 1980; 66: 1171–1174
   PubMed Web of Science ®Google Scholar
• Sakane T., Kotani H., Takada S., Murakawa Y., Ueda Y. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8 + suppressor T cell function. J. Immunol. 1983; 131: 753–761
   PubMed Web of Science ®Google Scholar
• Morimoto C., Steinberg A. D., Letvin N. L., Hagan M., Takeuchi T., Daley J., Levine H., Schlossman S. F. A defect of immunoregulatory T cell subsets in SLE patients demonstrated with anti-2H4 antibody. J. Clin. Invest. 1987; 79: 762–768
   PubMed Web of Science ®Google Scholar
• Delfraissy J. F., Segond P., Galanaud P., Wallond C., Massias P., Dormont J. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function. J. Clin. Invest 1980; 66: 141–148
   PubMed Web of Science ®Google Scholar
• Raziuddin S., Danial H. B., Kelley M. OKT4 + T cell abnormality in patients with active systemic lupus erythematosus: HLA-DR antigen expression. Clin. Immunol. Immunopathol 1988; 48: 42–49
   PubMedGoogle Scholar
• Alcocer-Varela J., Alarcon-Riquelme M., Laffon A., Sanchez-Madrid F., Alarcon-Segovia D. Activation markers on peripheral blood T cells from patients with active or inactive systemic lupus erythematosus. Correlation with proliferative responses and production of IL2. J. Autoimmunity 1991; 4: 935–945
   PubMed Web of Science ®Google Scholar
• Doveren R. F.C., van der Lieden C. J., Sponken E. E.M., Groenewegen G., Buurman W. A. Canine MHC—Class II antigens on B and T lymphocytes. Tissue Antigens 1986; 27: 87–98
   PubMedGoogle Scholar
• Schuening F., Stor B. R., Goehle S., Meyer J., Graham T., Deeg H. J., Pesando J. Canine pluripotent hematopoietic stem cells and CFU-GM express la-like antigens as recognized by two different classll-specific monoclonal antibodies. Blood 1987; 69: 165–172
   PubMed Web of Science ®Google Scholar
• Doxiadis I., Krumbacher K., Neefjes J. J., Ploegh Grosse H.-L., Wilde H. Biochemical evidence that the DLA-B locus codes for class II determinant expressed on all canine peripheral blood lymphocytes. Expl. Clin. Immunogenet. 1989; 6: 219–224
   PubMedGoogle Scholar
• Becker H., Weber G., Storch S., Federlin K. Relationship between CD5 + B lymphocytes and the activity of systemic autoimmunity. Clin. Immunol. Immunopathol. 1990; 56: 219–225
   PubMedGoogle Scholar
• Kantor A. B. The development and repertoire of B-1 cells (CD 5 B cells). Immunol. Today 1991; 12: 389–391
   PubMedGoogle Scholar
• Cobbold S. P., Qin S., Leong L. Y.W., Martin G., Waldmann H. Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol. Rev. 1992; 129: 165–201
   PubMed Web of Science ®Google Scholar
• Waldmann H., Cobbold S. P. The use of monoclonal antibodies to achieve immunological tolerance. Immunol. Today 1993; 14: 247–251
   PubMedGoogle Scholar